Published in N Engl J Med on August 18, 2011
The interleukin-1 family: back to the future. Immunity (2013) 3.90
PSORS2 is due to mutations in CARD14. Am J Hum Genet (2012) 2.10
Immunology of psoriasis. Annu Rev Immunol (2014) 2.06
The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. Trends Immunol (2013) 1.59
Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk. J Clin Invest (2012) 1.58
Association with Genetic Variants in the IL-23 and NF-κB Pathways Discriminates between Mild and Severe Psoriasis Skin Disease. J Invest Dermatol (2015) 1.41
Monogenic autoinflammatory diseases: concept and clinical manifestations. Clin Immunol (2013) 1.40
Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation. J Exp Med (2012) 1.39
The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation. Nat Immunol (2017) 1.38
Lighting the fires within: the cell biology of autoinflammatory diseases. Nat Rev Immunol (2012) 1.34
Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1. Clin Exp Immunol (2012) 1.30
Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity. J Biol Chem (2011) 1.28
Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis. Curr Rheumatol Rep (2012) 1.12
New Insights in the Immunobiology of IL-1 Family Members. Front Immunol (2013) 1.12
IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist. Proc Natl Acad Sci U S A (2012) 1.09
Putting together the psoriasis puzzle: an update on developing targeted therapies. Dis Model Mech (2012) 1.09
IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin. J Immunol (2014) 1.08
Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. Annu Rev Immunol (2015) 1.08
Psoriasis and other complex trait dermatoses: from Loci to functional pathways. J Invest Dermatol (2011) 1.07
Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kind. Curr Opin Immunol (2015) 1.03
AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 trafficking. Am J Hum Genet (2014) 1.00
Cytokines in psoriasis. Cytokine (2015) 0.98
Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation. Rheum Dis Clin North Am (2013) 0.98
Autoinflammatory pustular neutrophilic diseases. Dermatol Clin (2013) 0.97
The immunogenetics of Psoriasis: A comprehensive review. J Autoimmun (2015) 0.95
IL-36γ (IL-1F9) is a biomarker for psoriasis skin lesions. J Invest Dermatol (2014) 0.93
IL-36γ/IL-1F9, an innate T-bet target in myeloid cells. J Biol Chem (2012) 0.92
Generalized pustular psoriasis triggered by amoxicillin in monozygotic twins with compound heterozygous IL36RN mutations: comment on the article by Navarini et al. J Invest Dermatol (2013) 0.91
Chronic cutaneous pustulosis due to a 175-kb deletion on chromosome 2q13: excellent response to anakinra. Arch Dermatol (2012) 0.91
The severity of experimental arthritis is independent of IL-36 receptor signaling. Arthritis Res Ther (2013) 0.90
Gene mutation analysis in a korean patient with early-onset and recalcitrant generalized pustular psoriasis. Ann Dermatol (2014) 0.89
Loss of IL36RN function does not confer susceptibility to psoriasis vulgaris. J Invest Dermatol (2013) 0.89
IL-36α exerts pro-inflammatory effects in the lungs of mice. PLoS One (2012) 0.88
From bench to bedside and back again: translational research in autoinflammation. Nat Rev Rheumatol (2015) 0.87
Blockade of IL-36 receptor signaling does not prevent from TNF-induced arthritis. PLoS One (2014) 0.86
Psoriasis. Cold Spring Harb Perspect Med (2014) 0.85
Untangling the web of systemic autoinflammatory diseases. Mediators Inflamm (2014) 0.85
When less is more: primary immunodeficiency with an autoinflammatory kick. Curr Opin Allergy Clin Immunol (2014) 0.84
DIRA, DITRA, and new insights into pathways of skin inflammation: what's in a name? Arch Dermatol (2012) 0.84
A Case of Old Age-Onset Generalized Pustular Psoriasis with a Deficiency of IL-36RN (DITRA) Treated by Granulocyte and Monocyte Apheresis. Case Rep Dermatol (2015) 0.83
Palmoplantar Pustular Psoriasis Is Associated with Missense Variants in CARD14, but Not with Loss-of-Function Mutations in IL36RN in European Patients. J Invest Dermatol (2015) 0.83
Deep Sequencing of the T-cell Receptor Repertoire Demonstrates Polyclonal T-cell Infiltrates in Psoriasis. F1000Res (2015) 0.81
Decreased Langerhans cell responses to IL-36γ: altered innate immunity in patients with recurrent respiratory papillomatosis. Mol Med (2014) 0.80
Unprocessed Interleukin-36α Regulates Psoriasis-Like Skin Inflammation in Cooperation With Interleukin-1. J Invest Dermatol (2015) 0.80
Accelerating translational research by clinically driven development of an informatics platform--a case study. PLoS One (2014) 0.80
Neutrophil Elastase-mediated proteolysis activates the anti-inflammatory cytokine IL-36 Receptor antagonist. Sci Rep (2016) 0.80
Interleukin-1 family cytokines and their regulatory proteins in normal pregnancy and pre-eclampsia. Clin Exp Immunol (2015) 0.80
IL-6 as a druggable target in psoriasis: focus on pustular variants. J Immunol Res (2014) 0.79
Update on psoriasis immunopathogenesis and targeted immunotherapy. Semin Immunopathol (2015) 0.79
Recent advances in understanding psoriasis. F1000Res (2016) 0.79
Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2013 MauiDerm Meeting. J Clin Aesthet Dermatol (2013) 0.79
Genetics: Deep exploration. Nature (2012) 0.79
Role of IL-38 and its related cytokines in inflammation. Mediators Inflamm (2015) 0.79
Decreased expression of interleukin-36α predicts poor prognosis in colorectal cancer patients. Int J Clin Exp Pathol (2014) 0.79
Interleukin-1 Family Cytokines in Liver Diseases. Mediators Inflamm (2015) 0.79
Discovery in genetic skin disease: the impact of high throughput genetic technologies. Genes (Basel) (2014) 0.78
The expanding spectrum of rare monogenic autoinflammatory diseases. Orphanet J Rare Dis (2013) 0.78
Gene hunting in autoinflammation. Clin Transl Allergy (2013) 0.77
Pustular psoriasis complicated with acute generalized exanthematous pustulosis. J Dermatol Case Rep (2014) 0.77
Application of IL-36 receptor antagonist weakens CCL20 expression and impairs recovery in the late phase of murine acetaminophen-induced liver injury. Sci Rep (2015) 0.77
[Autoinflammatory syndromes in childhood]. Z Rheumatol (2015) 0.77
Cathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36γ. Proc Natl Acad Sci U S A (2017) 0.77
Redox distress and genetic defects conspire in systemic autoinflammatory diseases. Nat Rev Rheumatol (2015) 0.76
Neutrophils in animal models of autoimmune disease. Semin Immunol (2016) 0.76
Regulating against the dysregulation: new treatment options in autoinflammation. Semin Immunopathol (2015) 0.76
Neutrophilic dermatoses and autoinflammatory diseases with skin involvement-innate immune disorders. Semin Immunopathol (2015) 0.75
Severe erytrodermic psoriasis in child twins: from clinical-pathological diagnosis to treatment of choice through genetic analyses: two case reports. BMC Res Notes (2014) 0.75
Acute Generalized Exanthematous Pustulosis: Pathogenesis, Genetic Background, Clinical Variants and Therapy. Int J Mol Sci (2016) 0.75
Increased IL17A, IFNG, and FOXP3 Transcripts in Moderate-Severe Psoriasis: A Major Influence Exerted by IL17A in Disease Severity. Mediators Inflamm (2016) 0.75
Cytokine and Chemokine Profile in Amicrobial Pustulosis of the Folds: Evidence for Autoinflammation. Medicine (Baltimore) (2015) 0.75
AP1S3 Mutations Cause Skin Autoinflammation by Disrupting Keratinocyte Autophagy and Up-Regulating IL-36 Production. J Invest Dermatol (2016) 0.75
Identification of Two Loci Associated with Generalized Pustular Psoriasis. J Invest Dermatol (2015) 0.75
A tale of two sisters: identical IL36RN mutations and discordant phenotypes. Br J Dermatol (2015) 0.75
IL-36 receptor deletion attenuates lung injury and decreases mortality in murine influenza pneumonia. Mucosal Immunol (2016) 0.75
Production of biologically active IL-36 family cytokines through insertion of N-terminal caspase cleavage motifs. FEBS Open Bio (2016) 0.75
Dermatology: Where are We Coming from and Where are We Going to? Front Med (Lausanne) (2014) 0.75
Mutations in IL36RN are associated with geographic tongue. Hum Genet (2016) 0.75
Elderly-Onset Generalized Pustular Psoriasis without a Previous History of Psoriasis Vulgaris. Case Rep Dermatol (2015) 0.75
STEAPs comprise a novel inflammatory nexus in pustular skin disorders. J Allergy Clin Immunol (2016) 0.75
Genetically defined autoinflammatory diseases. Oral Dis (2016) 0.75
DNAX-activating protein 10 (DAP10) membrane adaptor associates with receptor for advanced glycation end products (RAGE) and modulates the RAGE-triggered signaling pathway in human keratinocytes. J Biol Chem (2014) 0.75
A Case of Acute Generalized Pustular Psoriasis of von Zumbusch Triggered by Hypocalcemia. Case Rep Dermatol (2015) 0.75
Imiquimod Treatment Causes Systemic Disease in Mice Resembling Generalized Pustular Psoriasis in an IL-1 and IL-36 Dependent Manner. Mediators Inflamm (2016) 0.75
Monogenic Autoinflammatory Diseases with Mendelian Inheritance: Genes, Mutations, and Genotype/Phenotype Correlations. Front Immunol (2017) 0.75
A novel mutation in IL36RN underpins childhood pustular dermatosis. J Eur Acad Dermatol Venereol (2015) 0.75
Dermatologic Manifestations of Monogenic Autoinflammatory Diseases. Dermatol Clin (2017) 0.75
Generalized pustular psoriasis with a novel mutation of interleukin-36 receptor antagonist, responding to methotrexate. JAAD Case Rep (2015) 0.75
Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies. MAbs (2017) 0.75
A Brief History of IL-1 and IL-1 Ra in Rheumatology. Front Pharmacol (2017) 0.75
[Genetics of cryopyrin-associated periodic syndrome]. Z Rheumatol (2017) 0.75
Skin Manifestations of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritides. Clin Rev Allergy Immunol (2017) 0.75
IL-36γ is a crucial proximal component of protective type-1-mediated lung mucosal immunity in Gram-positive and -negative bacterial pneumonia. Mucosal Immunol (2017) 0.75
IL-36γ signaling controls the induced regulatory T cell-Th9 cell balance via NFκB activation and STAT transcription factors. Mucosal Immunol (2017) 0.75
[Autoinflammatory syndromes : Practical approach to diagnostics and therapy]. Z Rheumatol (2016) 0.75
Psoriasis: a mixed autoimmune and autoinflammatory disease. Curr Opin Immunol (2017) 0.75
Signs of innate immune activation and premature immunosenescence in psoriasis patients. Sci Rep (2017) 0.75
Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet (2007) 9.88
Lamin a truncation in Hutchinson-Gilford progeria. Science (2003) 8.01
Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A (2003) 7.64
Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science (2011) 6.19
TLR3 deficiency in patients with herpes simplex encephalitis. Science (2007) 5.86
Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet (2009) 5.84
Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity (2010) 5.43
Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood (2004) 5.10
Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet (2007) 4.99
Pyogenic bacterial infections in humans with MyD88 deficiency. Science (2008) 4.92
Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science (2003) 4.80
Herpes simplex virus encephalitis in human UNC-93B deficiency. Science (2006) 4.26
Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med (2010) 3.98
Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet (2003) 3.96
Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet (2003) 3.95
Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med (2008) 3.85
Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol (2009) 3.70
SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol (2003) 3.69
Mutations in TMEM216 perturb ciliogenesis and cause Joubert, Meckel and related syndromes. Nat Genet (2010) 3.66
B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol (2011) 3.66
Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med (2011) 3.63
Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol (2004) 3.50
High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood (2012) 3.44
Pleiotropic effects of CEP290 (NPHP6) mutations extend to Meckel syndrome. Am J Hum Genet (2007) 3.42
Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol (2006) 3.41
IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med (2011) 3.29
Leber congenital amaurosis: comprehensive survey of the genetic heterogeneity, refinement of the clinical definition, and genotype-phenotype correlations as a strategy for molecular diagnosis. Hum Mutat (2004) 3.07
Segregation at three loci explains familial and population risk in Hirschsprung disease. Nat Genet (2002) 3.07
Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol (2011) 3.05
Highly conserved non-coding elements on either side of SOX9 associated with Pierre Robin sequence. Nat Genet (2009) 3.03
Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol (2007) 2.98
The Meckel-Gruber syndrome gene, MKS3, is mutated in Joubert syndrome. Am J Hum Genet (2006) 2.96
Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. J Invest Dermatol (2009) 2.94
Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet (2004) 2.90
Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Sorèze 2009. J Am Acad Dermatol (2010) 2.87
De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet (2012) 2.86
Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med (2007) 2.85
Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma. J Exp Med (2010) 2.70
Using genomic inbreeding coefficient estimates for homozygosity mapping of rare recessive traits: application to Taybi-Linder syndrome. Am J Hum Genet (2006) 2.63
miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol (2008) 2.61
Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J Biol Chem (2004) 2.60
Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J Exp Med (2007) 2.59
The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat Immunol (2010) 2.55
Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet (2007) 2.55
Mutations at a single codon in Mad homology 2 domain of SMAD4 cause Myhre syndrome. Nat Genet (2011) 2.52
Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). Ann Neurol (2010) 2.48
Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity (2010) 2.47
B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J Exp Med (2010) 2.42
Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat Immunol (2012) 2.38
Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. Lancet Neurol (2013) 2.36
Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense. PLoS Genet (2009) 2.35
Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense. Immunol Rev (2008) 2.35
Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) (2010) 2.33
Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature (2012) 2.32
Familial Mediterranean fever among patients from Karabakh and the diagnostic value of MEFV gene analysis in all classically affected populations. Arthritis Rheum (2003) 2.32
Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med (2004) 2.32
Clinical study of 40 cases of incontinentia pigmenti. Arch Dermatol (2003) 2.29
Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine (Baltimore) (2010) 2.26
NF-1Score: a prediction score for internal neurofibromas in neurofibromatosis-1. J Invest Dermatol (2010) 2.25
Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction. Am J Hum Genet (2007) 2.22
ADAMTS10 mutations in autosomal recessive Weill-Marchesani syndrome. Am J Hum Genet (2004) 2.22
IL-36R ligands are potent regulators of dendritic and T cells. Blood (2011) 2.20
Life-threatening infectious diseases of childhood: single-gene inborn errors of immunity? Ann N Y Acad Sci (2010) 2.20
Rituximab for patients with refractory mucous membrane pemphigoid. Arch Dermatol (2011) 2.19
Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. J Exp Med (2003) 2.19
X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med (2006) 2.18